Avanos Medical, Inc. (AVNS)

Avanos Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	680.1	673.3	684.1	587	714.8	697.6
Revenue Growth (YoY)	-0.58%	-1.58%	16.54%	-17.88%	2.47%	6.94%
Cost of Revenue	297	293.6	289.9	287.8	343.9	295.4
Gross Profit	383.1	379.7	394.2	299.2	370.9	402.2
Selling, General & Admin	329.8	335	326.5	285.3	332.6	399.1
Research & Development	26.7	27.2	29.2	30.6	34.9	37.7
Operating Expenses	356.5	362.2	355.7	315.9	367.5	436.8
Operating Income	26.6	17.5	38.5	-16.7	3.4	-34.6
Interest Expense / Income	14.6	15	10	3.3	15.6	15
Other Expense / Income	69.9	62.3	-27.2	-15.1	50.7	14.4
Pretax Income	-57.9	-59.8	55.7	-4.9	-62.9	-64
Income Tax	4.3	2	5.2	-11.2	-33.9	-18.1
Net Income	-62.2	-61.8	50.5	6.3	-29	-45.9
Net Income Growth	-	-	701.59%	-	-	-
Shares Outstanding (Basic)	46	46	46	48	48	48
Shares Change	-0.85%	-0.15%	-3.51%	0.74%	-0.20%	1.06%
EPS (Basic)	-1.33	-1.32	1.08	0.13	-0.61	-0.96
EPS (Diluted)	-1.33	-1.32	1.07	0.13	-0.61	-0.96
EPS Growth	-	-	723.08%	-	-	-
Free Cash Flow	13.3	14.6	71.6	66.3	-22.7	-125.1
Free Cash Flow Per Share	0.29	0.31	1.54	1.38	-0.47	-2.61
Gross Margin	56.33%	56.39%	57.62%	50.97%	51.89%	57.65%
Operating Margin	3.91%	2.60%	5.63%	-2.84%	0.48%	-4.96%
Profit Margin	-9.15%	-9.18%	7.38%	1.07%	-4.06%	-6.58%
Free Cash Flow Margin	1.96%	2.17%	10.47%	11.29%	-3.18%	-17.93%
Effective Tax Rate	-	-	9.34%	-	-	-
EBITDA	2.1	1.3	113.4	36.7	-4.4	-12.1
EBITDA Margin	0.31%	0.19%	16.58%	6.25%	-0.62%	-1.73%
Depreciation & Amortization	45.4	46.1	47.7	38.3	42.9	36.9
EBIT	-43.3	-44.8	65.7	-1.6	-47.3	-49
EBIT Margin	-6.37%	-6.65%	9.60%	-0.27%	-6.62%	-7.02%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).